[Br:1][C:2]1[CH:3]=[CH:4][C:5]([N:8]2[CH2:13][CH2:12][CH:11]([OH:14])[CH2:10][CH2:9]2)=[N:6][CH:7]=1.[C:15](OC(=O)C)(=[O:17])[CH3:16].CCN(CC)CC>CN(C1C=CN=CC=1)C.C(Cl)Cl.[Cl-].[Na+].O>[C:15]([O:14][CH:11]1[CH2:12][CH2:13][N:8]([C:5]2[CH:4]=[CH:3][C:2]([Br:1])=[CH:7][N:6]=2)[CH2:9][CH2:10]1)(=[O:17])[CH3:16]
A mixture of 1-(5-bromopyridin-2-yl)piperidin-4-ol (200 mg, 0.78 mmol), acetic anhydride (0.16 mL, 1.7 mmol), DMAP (10 mg, 0.08 mmol), and Et3N (0.24 mL, 1.7 mmol) in CH2Cl2 (4 mL) was stirred at rt for 17 h. Brine was added and extracted with CH2Cl2, dried over MgSO4, filtered and concentrated to dryness. The crude product was triturated with water and the title compound was collected by vacuum filtration (203 mg, 88%). 1H NMR (400 MHz, CDCl3) δ 8.17 (d, J=2.2 Hz, 1H), 7.52 (dd, J=9.0 Hz, 2.5 Hz, 1H), 6.57 (d, 9.0 Hz, 1H), 5.01-4.95 (m, 1H), 3.9-3.85 (m, 2H), 3.35-3.28 (m, 2H), 2.07 (s, 3H), 1.99-1.92 (m, 2H), 1.74-1.65 (m, 2H); MS ESI 300.9 [M+H]+, calcd for [C12H15BrN2O2+H]+ 299.03.
読み込み中…
